Exhibitors at UBIFRANCE French Pavilion
Exhibitors at UBIFRANCE French Pavilion
Exhibitors at UBIFRANCE French Pavilion
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
EVEON<br />
345 rue Lavoisier<br />
Inovallée<br />
38330 MONTBONNOT SAINT MARTIN<br />
FRANCE<br />
Phone: +33 4 76 44 84 17<br />
Email: mco@eveon.eu<br />
Web site: www.eveon.eu/en/index.html<br />
Contact: Muriel COMBEAU<br />
Eveon presents the first completely autom<strong>at</strong>ic and programmable medical injection<br />
device, fully safe, for SQ, ID and IM administr<strong>at</strong>ion of drugs of viscosities from 1 to<br />
100cp.<br />
The product is declined in a pl<strong>at</strong>form of devices th<strong>at</strong> could be mono-dose or multidoses,<br />
single-use or reusable.<br />
These devices also address other high-value applic<strong>at</strong>ions such as autom<strong>at</strong>ic LYO<br />
reconstitution or/and autom<strong>at</strong>ic mixing or/and dual injection.<br />
FLAMEL TECHNOLOGIES<br />
33 avenue du Dr Georges Levy<br />
69693 VENISSIEUX - FRANCE<br />
Phone: +33 4 7278 34 34<br />
Fax: +33 4 72 78 34 35<br />
Email: licencing@flamel.com<br />
Web site: www.flamel.com<br />
Contact: Grégoire FRANOUX<br />
FLAMEL Technologies (Nasdaq : FLML) is a world leader in delivery systems for small<br />
and large molecule drugs. The company, headquartered in Lyon, France, uses two<br />
innov<strong>at</strong>ive technology pl<strong>at</strong>forms, Micropumps ® and Medusa ® , to develop better and<br />
safer drugs tackling unmet medical needs.<br />
Flamel has 270 employees (70 PhDs) and ongoing RD collabor<strong>at</strong>ions and license<br />
agreements with many of the leading pharmaceutical and biotechnology companies<br />
(including GSK, Merck-Serono, Baxter and Pfizer).<br />
38
Change language